Skip to main content

Table 2 Summary of effect of the different statins on lipids. All doses combined.

From: Statins in hypercholesterolaemia: A dose-specific meta-analysis of lipid changes in randomised, double blind trials

 

Trials with data:

Patients on statin

 

Weighted mean change

Statin

Baseline

Outcome

Randomised

Analysed

Baseline TC

Absolute

Percent

Total cholesterol

       

Atorvastatin

5

5

1334

1334

7.2

-2.0

-27

Cerivastatin

4

4

2316

2316

7.4

-1.6

-22

Fluvastatin

9

9

1209

1209

7.5

-1.6

-21

Lovastatin

13

13

8561

8394

6.9

-1.2

-17

Pravastatin

44

43

11811

9730

6.6

-1.3

-20

Rosuvastatin

4

4

1005

1005

7.2

-2.2

-31

Simvastatin

31

31

17168

17168

6.1

-1.6

-25

Placebo

47

45

25081

22617

6.2

0.004

0.07

LDL

       

Atorvastatin

5

5

1334

1334

5.0

-1.8

-36

Cerivastatin

5

5

2828

2828

5.2

-1.4

-26

Fluvastatin

9

8

1209

1022

5.3

-1.6

-30

Lovastatin

13

13

8561

8561

4.8

-1.5

-30

Pravastatin

44

44

11811

11811

4.5

-1.2

-27

Rosuvastatin

4

4

1005

1005

4.8

-2.2

-46

Simvastatin

30

30

17143

17143

4.0

-1.4

-34

Placebo

48

42

25277

14832

4.1

-0.2

-6

HDL

       

Atorvastatin

5

5

1334

1334

1.3

0.1

7

Cerivastatin

4

4

2316

2316

1.3

0.1

7

Fluvastatin

9

8

1209

1022

1.3

0.1

7

Lovastatin

13

13

8561

8561

1.2

0.1

7

Pravastatin

43

43

9730

9730

1.1

0.1

12

Rosuvastatin

4

4

1005

1005

1.0

0.1

9

Simvastatin

30

29

17143

16913

1.1

0.1

6

Placebo

48

44

24921

19039

1.1

0.04

3

Triglycerides

       

Atorvastatin

5

5

1334

1334

2.0

-0.3

-17

Cerivastatin

5

5

2998

2998

2.1

-0.3

-13

Fluvastatin

9

8

1209

1022

1.9

-0.2

-10

Lovastatin

13

13

8561

8561

1.8

-0.3

-15

Pravastatin

44

43

11811

9730

1.8

-0.2

-12

Rosuvastatin

4

4

1005

1005

2.0

-0.4

-18

Simvastatin

29

29

17014

17014

2.0

-0.4

-17

Placebo

45

44

22869

19373

2

0.1

7